Skip to main content
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
5.44
+0.11 (2.06%)
Dec 26, 2024, 12:42 PM EST - Market open

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $65.20M in the quarter ending September 30, 2024, a decrease of -2.49%. This brings the company's revenue in the last twelve months to $276.92M, down -33.99% year-over-year. In the year 2023, Maravai LifeSciences Holdings had annual revenue of $288.95M, down -67.28%.

Revenue (ttm)
$276.92M
Revenue Growth
-33.99%
P/S Ratio
2.61
Revenue / Employee
$426,031
Employees
650
Market Cap
1.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Evolent Health 2.46B
Novavax 885.19M
U.S. Physical Therapy 639.06M
Alphatec Holdings 572.74M
MiMedx Group 342.80M
RxSight 128.29M
Ocular Therapeutix 61.44M
Revenue Rankings

MRVI News

More News